Antidepressants and risks of suicide and suicide attempts: A 27-year observational study

Journal of Clinical Psychiatry

Volumn 72, Issue 5, 2011, Pages 580-586

  Leon, Andrew C ^a   Solomon, David A ^c,d   Li, Chunshan ^a   Fiedorowicz, Jess G ^e   Coryell, W H ^e   Endicott, Jean ^b   Keller, Martin B ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c BROWN UNIVERSITY   (United States)

^d UpToDate   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; ISOCARBOXAZID; LITHIUM CARBONATE; MIRTAZAPINE; NORTRIPTYLINE; OLEPTRO; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK REDUCTION; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; UNITED STATES;

ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CONFIDENCE INTERVALS; DEPRESSIVE DISORDER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; PROPENSITY SCORE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SUICIDE; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 79959226688     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06552     Document Type: Article

References (27)

1. United States Food and Drug Administration. Briefing document for Psychopharmacologic Drugs Advisory Committee, December 13, 2006. page 38. http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf. Accessed February 7, 2011.
2. United States Food and Drug Administration. Labeling change request letter for antidepressant medications. http://www.fda.gov/Drugs/DrugSafety/ InformationbyDrugClass/ucm096352.htm. Updated February 25, 2009. Accessed February 7, 2011.
3. United States Food and Drug Administration. Revisions to product labeling. http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/ UCM173233.pdf Accessed February 7, 2011.
4. Keitner GI, Posternak MA, Ryan CE. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? J Clin Psychiatry. 2003;64(9):1091-1093. doi:10.408/JCP.v64n0915 PubMed
5. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 2002;159(3):469-473. doi:10.176/api.ajp.159.3.469 PubMed
6. Katz MM, Klerman GL. Introduction: overview of the clinical studies program. Am J Psychiatry. 1979;136(1):49-51. PubMed
7. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35(7):837-844. PubMed
8. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35(6):773-782. PubMed
9. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-548. PubMed
10. Leon AC, Hedeker DA. A mixed-effects quintile-stratified propensity adjustment for effectiveness analyses of ordered categorical doses. Stat Med. 2005;24(4):647-658. doi:10.102/sim.2042 PubMed (Pubitemid 40253613)
11. Leon AC, Hedeker D, Teres JJ. Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment. Stat Med. 2007;26(1):110-123. doi:10.102/sim.2458 PubMed (Pubitemid 46099420)
12. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55. doi:10.1093/biomet/70.1.41
13. Leon AC, Solomon DA, Mueller TI, et al. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry. 2003;160(4):727-733. doi:10.176/api.ajp.160.4.727 PubMed (Pubitemid 41079606)
14. Hedeker D, Siddiqui O, Hu FB. Random-effects regression analysis of correlated grouped-time survival data. Stat Methods Med Res. 2000;9(2):161-179. doi:10.191/09628067253473 PubMed (Pubitemid 30623558)
15. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics. 1968;24(2):295-313. doi:10.2307/2528036 PubMed
16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-748. PubMed
17. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, New York: John Wiley and Sons; 1981.
18. Hedeker D, Gibbons RD, Du Toit SHC, et al. SuperMix - A Program for Mixed-Effects Regression Models. Chicago, Illinois: Scientific Software International; 2008.
19. Endicott J, Cohen J, Nee J, et al. Hamilton Depression Rating Scale: extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1981;38(1):98-103. PubMed
20. Hollingshead AB, Redlich FC. Social Class and Mental Illness. New York, NY: John Wiley and Sons; 1958.
21. Klerman GL. Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. Psychopharmacol Bull. 1986;22(1):25-29. PubMed
22. Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ. 2009;180(3):291-297. PubMed
23. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry. 2007;164(7):1029-1034. doi:10.176/api.ajp.164.7.1029 PubMed (Pubitemid 47121391)
24. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163(1):41-47. doi:10.176/api.ajp.163.1.41 PubMed
25. Gibbons RD, Brown CH, Hur K, et al. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry. 2007;164(7):1044-1049. doi:10.176/api.ajp.164.7.104 PubMed (Pubitemid 47121393)
26. Drake C. Effects of misspecification of the propensity score on estimators of the treatment effect. Biometrics. 1993;49(4):1231-1236. doi:10.2307/25326 (Pubitemid 24045302)
27. Leon AC, Hedeker D. Quantile stratification based on a misspecified propensity score in longitudinal treatment effectiveness analyses of ordinal doses. Comput Stat Data Anal. 2007;51(12):6114-6122. (Pubitemid 47126009)